The original study, published in the journal Reproductive Sciences, aimed to provide a novel perspective on fertility treatment, exploring how natural compounds derived from plants—specifically phytoestrogens—might influence the endometrial environment in women trying to conceive. Clomiphene citrate functions primarily by blocking estrogen receptors in the hypothalamus, consequently stimulating the pituitary gland to produce more follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This hormonal surge is crucial for inducing ovulation, yet the potential of phytoestrogens to reverse unwanted side effects is where the study promised groundbreaking insights.

Yet, as the scientific community digested these findings, several researchers raised concerns regarding the robustness of the data and the integrity of the experimental design. The subsequent analyses suggested that the results presented in the initial paper may have been skewed or inadequately substantiated, leading to significant discrepancies in our understanding of phytoestrogen use in conjunction with clomiphene citrate. As it stands, this retraction could shift the direction of ongoing research toward alternative therapeutic strategies that maintain fidelity to established scientific norms and patient safety.

The implications of phytoestrogen supplementation during fertility treatments have drawn attention to both potential benefits and risks inherent in manipulating hormonal responses through dietary or supplemental interventions. Phytoestrogens, plant-derived compounds that exert estrogen-like effects, hold a complex position in reproductive health. Prior studies have indicated that adequate phytoestrogen intake can have beneficial effects, such as improving endometrial receptivity. However, the uncertain nature of their interactions with conventional medications like clomiphene citrate calls for a halt in their adoption until clearer evidence can delineate their roles.

Moreover, the retraction highlights the crucial role that peer review and accountability play in the dissemination of scientific knowledge. Rapid advancements in reproductive biology often predicate the circulation of findings that traders may misinterpret or oversimplify for public consumption. This caveat underlines the need for cautious interpretation of studies and highlights the importance of replicating findings before they can be adopted into clinical practice or consumer products. Clinical guidelines and fertility treatments must prioritize evidence anchored in rigorous investigation and transparent reporting.

In many ways, this incident serves as a reminder to practicing clinicians and researchers alike to adhere to rigorous methodological frameworks when investigating the intricacies of human reproduction. The potential impact of herbal and dietary supplements on reproductive health warrants carefully designed studies that account for numerous variables, including individual hormonal profiles and the interaction of multiple treatments. Every case of IUI is unique, and a blanket approach to treatment could lead to unforeseen consequences and misallocation of resources.

The retraction note also mirrors larger conversations surrounding the integration of alternative therapies into mainstream medicine. While the allure of natural remedies remains strong, especially in the context of women’s health, it becomes imperative to ensure that their implementation is based on sound scientific principles. The complexities of hormonal regulation highlight the dangers of assuming that “natural” is synonymous with “safe” or “efficacious.”

Throughout the research community, there is now a renewed call for transparency in reporting and a reaffirmation of best practices in study design. This recent retraction serves as an alarm for researchers and institutions alike to interrogate their findings comprehensively. Institutions must prioritize accuracy over expediency, ensuring that the credibility of scientific research is maintained in a landscape that values evidence-based practice.

As this narrative unfolds, the focus will likely shift toward understanding the ways in which dietary and lifestyle interventions can positively affect fertility, without compromising scientific rigor. It is vital to approach ongoing studies with caution and an eye toward ethical standards that prioritize patient welfare. Proper scrutiny and validation processes are paramount in ensuring that future findings can build upon the groundwork laid by past research while respecting the complexities of human biology.

In conclusion, the recent retraction of the research regarding phytoestrogens and clomiphene citrate underscores the importance of maintaining a high standard of scientific integrity. The turmoil surrounding this study serves as a clarion call for all within the scientific community to pursue truth with diligence and to safeguard patients through the decision-making processes. While the world of reproductive science continues to evolve, it is clear that robust, evidence-based inquiry remains the cornerstone of effective clinical practices.

In the aftermath of this significant retraction, it is crucial for researchers to scrutinize their methodologies and seek a deeper understanding of the myriad factors influencing fertility treatments. The road ahead will be marked by a reconsideration of how natural compounds are studied and incorporated into clinical regimes, with an eye to the future—where verification, transparency, and patient safety take precedence.

Subject of Research: The impact of phytoestrogens on the antiestrogenic effects of clomiphene citrate in intrauterine insemination patients.

Article Title: Retraction Note To: High Dose of Phytoestrogens Can Reverse the Antiestrogenic Effects of Clomiphene Citrate on the Endometrium in Patients Undergoing Intrauterine Insemination: A Randomized Trial.

Article References:

Unfer, V., Casini, M.L., Costabile, L. et al. Retraction Note To: High Dose of Phytoestrogens Can Reverse the Antiestrogenic Effects of Clomiphene Citrate on the Endometrium in Patients Undergoing Intrauterine Insemination: A Randomized Trial.
Reprod. Sci. (2026). https://doi.org/10.1007/s43032-025-02021-3

Image Credits: AI Generated

DOI:

Keywords: phytoestrogens, clomiphene citrate, intrauterine insemination, retraction, reproductive health, scientific integrity, evidence-based practice.

The original study posited that certain herbal extracts could impede the progression of diseases influenced by alpha-synuclein. Given the role of this protein in the formation of toxic aggregates, which threaten neuronal integrity, the researchers sought to leverage the therapeutic potential of traditional herbal remedies. By conducting a series of controlled experiments, the authors aimed to demonstrate that these natural substances could serve as effective modulators of alpha-synuclein-induced pathologies.

Inside the laboratory, the researchers meticulously analyzed various herbal extracts, delving into their biochemical compositions and potential neuroprotective effects. They formulated hypotheses around the interaction between these extracts and alpha-synuclein fibrils, believing that some compounds could inhibit the formation of these aggregates, thereby mitigating toxicity. Test results indicated that certain extracts showed promise in reducing oligomeric species of alpha-synuclein, thus indicating a potential pathway for therapeutic intervention.

However, despite the promising data and initial conclusions drawn, the research faced challenges of validation. Scrutiny within the scientific community led to discussions around reproducibility and methodological rigor. Subsequent evaluations raised flagging questions about the experimental design, statistical analyses, and data integrity. Ultimately, these discussions culminated in the issuance of a retraction note, signaling a stark reminder about the importance of transparency and accountability in scientific inquiry.

This episode reflects a broader phenomenon pervasive in scientific research wherein studies may fail to replicate favorable outcomes upon additional investigation. The medical research community often views retractions as necessary mechanisms for upholding scientific integrity, even as they complicate the trust that the public and fellow scientists place in published findings. The repercussions of this retraction extend to the credibility of alternative medicine, particularly as it intersects with fields like neurobiology that traditionally rely on conventional pharmacological approaches.

Varying perspectives emerged in response to the retraction. Some advocates for herbal medicine decried the retraction as a barrier to exploring potentially beneficial natural remedies. They asserted that the complexities of bioactive compounds from herbs often necessitate nuanced approaches to research that may not align with conventional scientific methodologies. Meanwhile, skeptics voiced concerns that relying on herbal interventions could distract from the need for rigorous drug development pathways guided by well-established clinical trials.

The discourse around this retraction opens a portal into broader discussions about the future of herbal medicine in treating neurodegenerative disorders. In the quest to find safer, more effective alternatives to conventional therapeutics, several researchers advocate for a integration of ethnobotanical knowledge and modern scientific techniques that emphasize precision in experimentation.

As debates surrounding herbal remedies continue to evolve, the scientific community is called to critically assess not only the efficacy but also safety profiles of these natural products. Failing to do so could compromise patient trust and slow the progress towards viable treatments for debilitating diseases like Parkinson’s.

This incident serves as an urgent reminder of the importance of peer review and oversight in scientific publishing. The processes of validation and affirmation are crucial to ensuring that findings presented in journals withstand the test of time and scrutiny. As new revelations emerge from rigorous research, it is vital that the scientific community prioritizes a culture of openness, fostering an environment that encourages honest and constructive criticism, rather than shielding studies from public light.

It is essential for researchers to remain vigilant against biases and to ensure that their studies are replicable and transparent. The path to scientific advancement often entails confronting failures and setbacks, but it is precisely these challenges that pave the way for growth and innovation.

While the retraction may have cast a shadow on the original study, it also highlights the necessity for researchers to approach their work with integrity, aspiring to contribute to a body of knowledge that will flourish in accuracy and relevance. As the dialogue between herbal medicine and modern science continues, only a vigilant and ethical approach will safeguard the interests of patients and the integrity of research.

The implications of this retraction extend far beyond a single study, prompting calls for reform around rigor in the study of herbal compounds. As the scientific community grapples with the aftermath, one critical question remains: How can we ensure that the quest for knowledge remains steadfast in the face of challenges?

In a landscape marked by rapid scientific innovation and interventional therapies, the delicate balance between exploration and validation is indispensable. As researchers turn their attention to the complexities of diseases that affect millions worldwide, it will be essential to carry forward lessons learned from this retraction, ultimately striving for excellence in scientific inquiry.

Respecting the journey of research, and recognizing not just the triumphs but also the trials that accompany it, can serve as a catalyst for more robust and informed pursuit of solutions that improve human health and well-being.

In conclusion, as the saga of this retracted study unfolds, the scientific community must remain resolute in its dedication to truth and reliability. Future endeavors should focus on tightening research methodologies and ensuring that findings are not only novel but replicable and applicable within the clinical framework.

Subject of Research: Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts

Article Title: Retraction Note: Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts

Article References:

Ardah, M.T., Ghanem, S.S., Abdulla, S.A. et al. Retraction Note: Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts. BMC Complement Med Ther 25, 421 (2025). https://doi.org/10.1186/s12906-025-05176-3

Image Credits: AI Generated

DOI: 10.1186/s12906-025-05176-3

Keywords: alpha-synuclein, herbal medicine, neurodegenerative disorders, retraction, research integrity.

Hydrazine and phenol are both compounds that pose a substantial risk to human health and the environment. Hydrazine is widely used in various industrial applications, including as a rocket fuel and in pharmaceuticals, but it is highly toxic and can cause severe health issues upon exposure. Similarly, phenol, often utilized in the manufacture of plastics and resins, is known for its harmful effects, including skin and respiratory irritation, and potential carcinogenic properties. The urgency to monitor these substances in water sources cannot be overstated, particularly as pollution continues to threaten ecosystems and public health.

The original article proposed the utilization of a modified carbon paste electrode, enhanced with a nanocomposite, to develop an efficient electrochemical sensor. The researchers aimed to demonstrate that this sensor could offer high sensitivity and specificity for detecting low concentrations of hydrazine and phenol, making it a promising tool for environmental monitoring. The study represented a fusion of advanced materials science and electroanalytical chemistry, highlighting the potential for new technologies to solve pressing environmental challenges.

Initially, the study received positive attention for its innovative approach and the promise it held for improving water quality monitoring. The method employed nanocomposite materials that significantly increased the electrode’s surface area, facilitating more effective electron transfer and chemical reactions. This was positioned as a game-changing advancement in sensor technology, potentially outpacing traditional methods that often lacked the required sensitivity for such hazardous compounds.

Despite these promising claims, the recent retraction indicates serious discrepancies in the research findings. Retraction serves as a critical mechanism in science to uphold the integrity and reliability of published work. When flaws are identified — whether they be methodological errors, data fabrication, or issues with reproducibility — retracting the publication becomes essential to maintain the credibility of scientific discourse. In this case, a detailed examination of the data and methodologies used in the initial study may have revealed inaccuracies or inconsistencies that warranted such a drastic step.

The retraction of this study opens several questions regarding the research process within scientific disciplines. It highlights the necessity for rigorous peer review and accountability among researchers. Furthermore, the scientific community must continually adapt and evolve its practices to ensure that groundbreaking technologies, like the proposed electrochemical sensor, withstand scrutiny and can be trusted by practitioners in the field.

The implications of this retraction extend beyond just the immediate authors and the specific research area. It underlines a broader trend in environmental science, where the stakes are high, and the responsibility toward public health and ecosystem stability is integral. As researchers strive to develop innovative solutions to combat pollution and protect natural resources, the need for transparency and meticulous methodology becomes paramount.

In light of this incident, there may be calls for stricter regulations and oversight when it comes to scientific publications, especially regarding studies with potentially far-reaching effects on public health and the environment. The demand for integrity and reproducibility in results should resonate throughout the academic community. Each retraction is a learning opportunity for the broader scientific field, paving the way for improved research practices and heightened awareness of ethical considerations.

Ultimately, while the retraction may be a setback for the authors and their ambitious project, it also serves as an important reminder of the complexities and challenges inherent in scientific research. The pursuit of knowledge and innovation must always be coupled with ethical responsibility and a commitment to accuracy. Future work will need to carefully consider these lessons to ensure that advancements in technology can genuinely benefit society, particularly in the critical realm of environmental monitoring.

The path forward for researchers in this field involves not only rectifying the issues surrounding this particular study but also fostering an environment where collaboration and rigorous examination of findings are prioritized. This incident serves as a motivator for scientists to engage in open dialogue about their methodologies and results, thereby promoting a culture of transparency and collective advancement in the pursuit of knowledge.

As this situation unfolds, the discourse surrounding the retraction will likely generate further insights into best practices moving forward. The scientific community will be watching closely to see how the authors and their collaborators respond to these challenges, with hopes that future research will yield the promising results that were originally anticipated.

By fostering an approach that balances innovation with a steadfast commitment to integrity, researchers can help ensure that their contributions lead to meaningful and lasting solutions to environmental challenges, particularly in detecting and mitigating harmful pollutants like hydrazine and phenol.

The journey of scientific discovery is fraught with both triumphs and trials. The retraction in question stands as a pivotal moment for all involved, a stark reminder that the quest for knowledge is as much about integrity and rigor as it is about ingenuity. As we move forward, let us embrace these lessons and strive for excellence in every aspect of research.

Subject of Research: Hydrazine and phenol detection in water and wastewater samples

Article Title: Retraction Note: An electrochemical nanocomposite modified carbon paste electrode as a sensor for simultaneous determination of hydrazine and phenol in water and wastewater samples.

Article References:

Karimi-Maleh, H., Moazampour, M., Ensafi, A.A. et al. Retraction Note: An electrochemical nanocomposite modified carbon paste electrode as a sensor for simultaneous determination of hydrazine and phenol in water and wastewater samples.
Environ Sci Pollut Res (2025). https://doi.org/10.1007/s11356-025-37198-2

Image Credits: AI Generated

DOI:

Keywords: Environmental monitoring, electrochemical sensor, hydrazine, phenol, nanocomposite, water quality.

The original study, authored by Pang, B., Wang, Y., Xu, K., and colleagues, addressed a critical intersection of geotechnical engineering and remote sensing technology. Their work sought to quantify how pile reinforcements interact with both cohesive soils, known for their complex plastic behavior, and cohesionless soils, characterized by granular particle interactions and frictional resistance. This focus on understanding slope stability through sophisticated numerical simulations represented a fresh direction in mitigating landslide risks and subsidence in vulnerable landscapes.

However, the retraction implies that underlying methodological or analytical issues may have compromised the validity of the conclusions drawn. While the retraction note itself does not elaborate on specific faults, the situation underscores the inherent challenges in applying numerical analysis to soil-structure interaction problems. Accurate modeling of pile reinforcement effects requires not only detailed soil behavior characterization but also precise calibration of boundary conditions and validation against empirical data sets—factors known to be demanding within geotechnical research.

The use of remote sensing as an assisting tool in this context was a particularly novel aspect of the research. Remote sensing technologies, such as LiDAR and satellite-based imagery, offer powerful means to monitor slope deformations and environmental changes over large spatial and temporal scales. Integrating these data sources with advanced finite element or finite difference models can potentially revolutionize predictive maintenance and hazard mitigation strategies in slope engineering. The retracted study aimed to demonstrate this integration’s feasibility, but the recent withdrawal raises questions about the robustness of such multidisciplinary approaches.

From a technical perspective, simulating pile reinforcement effects involves capturing the interaction mechanics between rigid structural elements and deformable soil substrates under various loading conditions. Cohesive soils, with their tendency for plastic deformation and shear strength governed by cohesion and internal friction angle, require complex constitutive models to predict failure mechanisms accurately. Cohesionless soils, lacking adhesive forces, rely heavily on effective stress principles and granular flow mechanics, which present distinct modeling challenges.

The research also attempted to quantify the beneficial influence of piles in stabilizing slopes prone to failure due to gravitational forces and hydrological factors. By reinforcing weaker soil layers, piles can redistribute stress, enhance slope stiffness, and prevent displacement. Yet, numerical models must carefully account for pile-soil interface properties, including friction and adhesion, to capture realistic behavior. Any oversimplification or computational error in this regard can significantly impact predictive reliability, casting doubt on conclusions about reinforcement efficacy.

The decision to retract this pivotal work reminds the scientific community of the vital role that peer review, data transparency, and reproducibility play in maintaining research integrity. In interdisciplinary studies marrying geotechnical modeling with remote sensing analytics, these principles become even more crucial, given the complexity and novelty of combining disparate data types and analytical frameworks. As such, the retraction may serve as a catalyst for establishing more rigorous standards in future investigations.

Moreover, this episode highlights the importance of continuous validation and calibration of numerical models using field observations and laboratory experiments. While numerical simulation offers unparalleled flexibility and insight into soil-structure interaction phenomena, it is inherently limited without empirical grounding. Models must be iteratively refined through real-world feedback loops to ensure their outputs are reliable for engineering decision-making.

In light of the retraction, researchers in geotechnical engineering and remote sensing are encouraged to revisit assumptions underlying their modeling approaches, particularly when addressing slope stabilization strategies. This includes considering heterogeneity in soil properties, dynamic environmental loads such as rainfall and seismic activity, and the nonlinear behavior of reinforcement elements under critical stress conditions. Enhanced computational resources and improved data acquisition methods should be leveraged to achieve these aims.

Furthermore, this development sheds light on the evolving nature of scientific understanding in earth sciences. The iterative process of publication, critique, correction, and sometimes withdrawal is intrinsic to scientific progress. Far from representing failure, retractions signify a commitment to the highest standards of accuracy and responsibility. The community’s response to such events often ultimately strengthens consensus and informs better practices.

As this case leaves numerous questions unanswered, it acts as a reminder of the imperative need for interdisciplinary collaboration. Geotechnical engineers, remote sensing experts, numerical modelers, and field practitioners must work closely to align methodologies, verify outputs, and translate findings into actionable solutions for slope management and hazard reduction.

Looking ahead, the fusion of advanced remote sensing data with robust numerical simulations remains a promising frontier. When executed with rigor and transparency, such integrated approaches could enable early warning systems for landslides, optimize design of slope reinforcement structures, and promote sustainable infrastructure development in challenging terrains globally.

In conclusion, the retraction of the paper by Pang et al. serves as a notable event in environmental earth sciences, revealing both the potential and the pitfalls of using numerical analysis to assess pile reinforcement effects on soil slopes. It emphasizes the necessity for meticulous methodological scrutiny, empirical validation, and open science practices in advancing this critical area of research. The journey towards safer, more resilient slopes continues, informed by lessons learned from this reflective moment in scientific inquiry.

Subject of Research: Numerical analysis of pile reinforcement effects on cohesive and cohesionless soil slopes with applications in remote sensing-assisted engineering.

Article Title: Retraction Note: Numerical analysis of pile reinforcement effect on cohesive and cohesionless soil slopes for assisting remote sensing.

Article References:
Pang, B., Wang, Y., Xu, K. et al. Retraction Note: Numerical analysis of pile reinforcement effect on cohesive and cohesionless soil slopes for assisting remote sensing. Environ Earth Sci 84, 660 (2025). https://doi.org/10.1007/s12665-025-12700-8

Image Credits: AI Generated

Long noncoding RNAs (lncRNAs) have surged to the forefront of cancer research in recent years, captivating scientists with their complex regulatory roles across various aspects of gene expression and cellular dynamics. Among them, GAS5 (growth arrest-specific transcript 5) had emerged as a promising biomarker and functional mediator, purportedly influencing tumor cell proliferation and serving as an indicator of poor clinical prognosis within colorectal malignancies. The retracted study initially presented compelling evidence linking GAS5 expression levels with disease progression metrics, thereby offering hope for improved prognostic models.

However, the retraction reflects concerns over data validity and reproducibility—cornerstones of scientific integrity. While the specific reasons for withdrawal have not been exhaustively detailed in the public retraction notice, suspicions about experimental inconsistencies and potential methodological oversights prompt a vital reevaluation of conclusions previously assumed to be established. This situation echoes similar historical instances within cancer genomics research, illustrating the ongoing challenges in characterizing lncRNA functions with the necessary precision.

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, compelling researchers to unearth molecular targets that can predict patient outcomes or serve as therapeutic entry points. Long noncoding RNAs, by modulating chromatin remodeling, transcriptional control, and post-transcriptional modifications, theoretically offer a sophisticated layer of regulation exploitable for diagnostic and therapeutic innovation. The initial excitement surrounding GAS5 stemmed from its purported role as a suppressor of proliferation, as well as a facilitator of apoptosis in colorectal cancer cells, supporting its candidacy as both a biomarker and treatment target.

Scientific enthusiasm, however, must be tempered by stringent validations. The retraction of this particular research compels the scientific community to scrutinize the experimental designs utilized in lncRNA studies, notably techniques such as quantitative PCR, RNA interference, and in vitro proliferation assays, which were central to the original conclusions. Artifact introduction, sample contamination, or analytical biases can severely skew results and lead to misleading interpretations, as might have been the case here.

The ramifications of this retraction extend beyond the academic circles, influencing ongoing clinical trial designs and biomarker-driven therapies predicated on GAS5-associated pathways. Clinical researchers and pharmaceutical developers must recalibrate their investigative priorities and validate alternative molecular players within the colorectal cancer landscape. This pivot may also invigorate interest in other lncRNAs such as HOTAIR, MALAT1, or NEAT1, which have independently demonstrated credible oncogenic or tumor-suppressive roles.

Moreover, this development accentuates the imperative of reproducibility in cancer biology research. The reproducibility crisis, which has quietly plagued biomedical sciences, demands transparent methodologies, robust statistical analyses, and data-sharing frameworks. Journals and funding bodies are increasingly emphasizing these norms to avoid cascades of invalidated research that hamper progress and erode public trust.

Beyond colorectal cancer, the implication of GAS5 in diverse cancers highlights the complexity and heterogeneity of lncRNA functions according to cellular and tissue contexts. The dynamic interplay between epigenetic modifications, lncRNA localization, and interaction with RNA-binding proteins constructs a nuanced regulatory network that resists oversimplification. The failed extrapolation or overinterpretation of such data can culminate in premature claims, as seemingly occurred in this now-retracted study.

Encouragingly, the retraction may steer researchers towards more integrative approaches that combine transcriptomics with epigenomics, proteomics, and functional assays in patient-derived models. Such multi-omics strategies enable the dissection of lncRNA biology within physiologically relevant contexts and offer comprehensive insights into their roles in tumor microenvironments, metastatic potential, and treatment resistance mechanisms.

The authors’ decision to retract—though difficult—exemplifies scientific responsibility and highlights the evolving nature of biomedical knowledge, where hypotheses are continuously tested, challenged, and refined. While this event punctuates a chapter on GAS5’s involvement in colorectal cancer, it opens avenues for more rigorous inquiry, reinforcing that the path to breakthroughs is seldom linear.

As the oncology field digests this news, it also reflects on the pressures endemic to high-stakes molecular cancer research, such as publication bias and the race for novel discoveries, which sometimes inadvertently incentivize premature conclusions. Establishing collaborative consortia and cross-validation datasets could serve as buffers against similar lapses.

In the wake of this retraction, clinicians and researchers alike should exercise caution before integrating GAS5-targeted diagnostics or therapies into practice. Independent replication studies and meta-analyses will be critical to validate other lncRNAs’ potential as reliable biomarkers in colorectal cancer prognosis. This collective caution will safeguard patient interests and optimize the translational relevance of basic research.

Furthermore, this scenario serves as a potent reminder of the scientific method’s self-correcting nature. Science advances through trials and errors, corrections, and iterations, aimed at converging on truths rather than infallible results. Transparency in declaring uncertainties and errors, as demonstrated here, fortifies the reliability of scientific discourse and underpins trust among stakeholders.

In conclusion, the retraction of the GAS5 colorectal cancer study represents a pivotal moment in lncRNA research, underscoring both the promising avenues and intrinsic challenges of molecular oncology. The community’s response—marked by reflection, method refinement, and renewed rigor—will ultimately determine the trajectory of elucidating complex RNA-mediated regulation in cancer biology.

Subject of Research: Long noncoding RNA GAS5 influences on cell proliferation and prognosis in colorectal cancer (retracted)

Article Title: Retraction Note to: Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer

Article References:
Yin, D., He, X., Zhang, E. et al. Retraction Note to: Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol 42, 521 (2025). https://doi.org/10.1007/s12032-025-03070-z

Image Credits: AI Generated